Department of Physiology and Biophysics, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois;
Am J Physiol Cell Physiol. 2013 Dec 1;305(11):C1114-22. doi: 10.1152/ajpcell.00166.2013. Epub 2013 Aug 28.
Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; the National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. N Engl J Med 354: 229-240, 2006]. Surprisingly, these benefits are long-lasting and are diminished by the epithelial Na(+) channel blocker amiloride (Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006). Our aim was to explain these effects. Human bronchial epithelial (hBE) cells from CF lungs were grown in inserts and were used in three experimental approaches: 1) Ussing chambers to measure amiloride-sensitive short-circuit currents (INa); 2) continuous perfusion Ussing chambers; and 3) near "thin-film" conditions in which the airway surface of the inserts was exposed to a small volume (30 μl) of isosmotic or HS solution as the inserts were kept in their incubation tray and were subsequently used to measure INa under isosmotic conditions (near thin-film experiments; Tarran R, Boucher RC. Methods Mol Med 70: 479-492, 2002). HS solutions (660 mosmol/kgH2O) were prepared by adding additional NaCl to the isosmotic buffer. The transepithelial short-circuit current (ISC), conductance (GT), and capacitance (CT) were measured by transepithelial impedance analysis (Danahay H, Atherton HC, Jackson AD, Kreindler JL, Poll CT, Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006; Singh AK, Singh S, Devor DC, Frizzell RA, van Driessche W, Bridges RJ. Methods Mol Med 70: 129-142, 2002). Exposure to apical HS inhibited INa, GT, and CT. The INa inhibition required 60 min of reexposure to the isosmotic solution to recover 75%. The time of exposure to HS required to inhibit INa was <2.5 min. Under near thin-film conditions, apical exposure to HS inhibited INa, but as osmotically driven water moved to the apical surface, the aqueous apical volume increased, leading to an amiloride-insensitive decrease in its osmolality and to recovery of INa that lagged behind the osmotic recovery. Amiloride significantly accelerated the recovery of INa following exposure to HS. Our conclusions are that exposure to HS inhibits hBE INa and that amiloride diminishes this effect.
高渗盐水(HS)吸入疗法有益于囊性纤维化(CF)患者[Donaldson SH、Bennet WD、Zeman KL、Knowles MR、Tarran R、Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR、Robinson M、Rose BR、Harbour C、Moriarty CP、Marks GB、Belousova EG、Xuan W、Bye PT; 国家高渗盐水在囊性纤维化(NHSCF)研究组。N Engl J Med 354: 229-240, 2006]。令人惊讶的是,这些益处是持久的,并且被上皮钠通道阻滞剂阿米洛利(Donaldson SH、Bennet WD、Zeman KL、Knowles MR、Tarran R、Boucher RC. N Engl J Med 354: 241-250, 2006)减弱。我们的目的是解释这些影响。从 CF 肺部生长的人支气管上皮(hBE)细胞在插入物中生长,并用于三种实验方法:1)Ussing 室测量阿米洛利敏感的短路电流(INa);2)连续灌注 Ussing 室;3)在“薄膜”条件下,插入物的气道表面暴露于少量(30 μl)等渗或 HS 溶液,而插入物保持在其孵育盘中,并随后用于在等渗条件下测量 INa(薄膜实验附近;Tarran R、Boucher RC. Methods Mol Med 70: 479-492, 2002)。HS 溶液(660 mosmol/kgH2O)通过向等渗缓冲液中添加额外的 NaCl 来制备。通过跨上皮阻抗分析测量跨上皮短路电流(ISC)、电导(GT)和电容(CT)(Danahay H、Atherton HC、Jackson AD、Kreindler JL、Poll CT、Bridges RJ. Am J Physiol Lung Cell Mol Physiol 290: L558-L569, 2006;Singh AK、Singh S、Devor DC、Frizzell RA、van Driessche W、Bridges RJ. Methods Mol Med 70: 129-142, 2002)。HS 的顶端暴露抑制了 INa、GT 和 CT。恢复 75%需要 60 分钟重新暴露于等渗溶液来抑制 INa。抑制 INa 所需的 HS 暴露时间<2.5 分钟。在薄膜条件下,顶端暴露于 HS 抑制了 INa,但由于渗透压驱动的水移动到顶端表面,顶端的水体积增加,导致阿米洛利不敏感的渗透压降低,并滞后于渗透压恢复恢复 INa。阿米洛利显著加速了 HS 暴露后 INa 的恢复。我们的结论是,HS 暴露抑制 hBE INa,阿米洛利减弱了这种作用。